Please login to the form below

Not currently logged in
Email:
Password:

New accounts: January

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to Novemeber 2005 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period October to Novemeber 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

 

GlaxoSmithKline

Cervarix

Cervical cancer (consumer healthcare)

Clew Communications

GrÈnenthal

New product launch

N/A

Jango Communications

Haemophilia Society

N/A

Corporate

Red Door Communications

LiDCO

LiDCO

Intensive care medicine

Reynolds-MacKenzie

Novartis

Exjade

Sickle cell disease

Avenue

Novartis

Glivec

Oncology - GIST

Avenue

Novartis

Transplantation portfolio

Transplantation

LeapFrog Medical

Pfizer

Injectable contraceptive

Contraception

Ruder Finn

Procter & Gamble

Asacol

Inflammatory bowel disease

Resolute Communications

Roche

Avastin

Oncology

Ketchum

Solvay

Omacor

Cardiology

LeapFrog Medical

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics